U.S. President Donald Trump said at a news conference Monday that a new vaccine will be available to the American public this year, “perhaps much earlier than the end of the year,”media BGR reported. Several companies are already in late-stage trials for the COVID-19 vaccine, and some may seek approval by the end of 2020.
At a White House news conference Monday, Mr. Trump said the United States is on track to provide vaccines to the public by 2020, perhaps even sooner than many expected.
“We’re balancing speed and safety, and we’re getting the vaccine as planned this year, probably a lot earlier than at the end of the year,” Trump said. “And we are producing the most promising candidate vaccine soure ahead of schedule to be ready once approved.” Our troops have been lined up, it’s logistical, it’s all about logistics. “
In his press conference, Mr. Trump referred to Moderna and Pfizer, both of which entered late-stage trials of their vaccines. As part of the trial, he said, “hundreds” of people had been vaccinated. Pfizer is also one of the companies that receives significant funding from the U.S. government as part of Operation Warp Speed, which aims to provide 300 million doses of safe and effective COVID-19 vaccine by January 2021. Mr. Trump seems to believe that at least one candidate vaccine will do so.
Even if a vaccine can pass a phase 3 trial and be approved for use by the U.S. government, there will be some logistical challenges, according to themedia BGR. If a person needs two doses of the vaccine, the amount the company needs to produce will double. Then there are the medical devices that states need to distribute and manage vaccines, as well as the messaging and coordination of information to ensure that as many Americans as possible get vaccinated. In other words, having a vaccine is only the first step in a lot of work.